9 Results for "

OPRM

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "OPRM" in MCE Product Catalog:

Cat. No.: HY-136832
CAS No.: 110514-35-7
Noribogaine hydrochloride is an orally active, blood-brain barrier permeable SERT inhibitor (IC50=50-300 nM) and hERG channel blocker. Noribogaine hydrochloride enhances serotonergic transmission, activates the κ-opioid receptor (OPRK) G protein signaling pathway and inhibits β-arrestin recruitment. Meanwhile, Noribogaine hydrochloride blocks the μ-opioid receptor (OPRM) signaling pathway as well as ion channels associated with cardiac repolarization. Noribogaine hydrochloride induces neuritogenesis, upregulates GDNF mRNA expression, and modulates opioid tolerance. Noribogaine hydrochloride reduces alcohol-seeking behavior in experimental animals, and is widely used in studies related to depression, addiction, alcoholism, and cardiotoxicity .
loading...
    loading...
Cat. No.: HY-124819
CAS No.: 957471-96-4
Target:  

Bacterial

Research Areas:  

Infection

D13-9001 is a potent AcrB (AcrAB-TolC efflux pump subunit) and MexB (MexAB-OprM efflux pump subunit) inhibitor with the KD values of 1.15 μM and 3.57 μM in E. coli and P. aeruginosa, respectively . D13-9001 exhibits antibiotic activities .
loading...
    loading...
Cat. No.: HY-RS09806
Research Areas:  

Others

OPRM1 Human Pre-designed siRNA Set A contains three designed siRNAs for OPRM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-116163
CAS No.: 1565852-90-5
Synonyms: CYM50202
Target:  

Endogenous Metabolite

Research Areas:  

Others

ML350 (CYM50202) is a highly potent OPRK1 antagonist with selectivity and broad biological applications. With IC50 values of 9-16 nM, ML350 shows high selectivity for OPRK1, with selectivity of 219-382-fold and 20-35-fold relative to OPRD1 and OPRM1, respectively. ML350 exhibited favorable characteristics in in vivo pharmacokinetic analysis, including high passive membrane permeability and moderate human plasma protein binding. Extensive screening of ML350 against multiple ion channels, receptors, and transporters showed that it does not have adverse off-target effects .
loading...
    loading...
Cat. No.: HY-W414109
CAS No.: 1172882-21-1
Research Areas:  

Neurological Disease

ID110460002 possesses both full agonist activity at the μ-opioid receptor (OPRM) and agonist activity at the δ-opioid receptor (OPRD). ID110460002 acts as a potent agonist for the G protein pathways of both receptors, but exhibits only very weak partial agonist activity towards the β-arrestin-2 pathway. The agonistic potency of ID110460002 at OPRM has extremely high intrinsic activity and is unaffected by reduced receptor expression levels, while its potency at OPRD depends on receptor expression levels. ID110460002 displays tissue- or organ-dependent properties, and serves as a critical compound for investigating pain mechanisms and analgesia .
loading...
    loading...
Cat. No.: HY-P702403
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Mu-type opioid receptor; Mu opiate receptor; Mu opioid receptor; MOP; hMOP
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P811024
Synonyms: MOR1, OPRM1, Mu-type opioid receptor, M-OR-1, MOR-1, Mu opiate receptor, Mu opioid receptor, MOP, hMOP

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P811139
Synonyms: MOR1, OPRM1, Mu-type opioid receptor, M-OR-1, MOR-1, Mu opiate receptor, Mu opioid receptor, MOP, hMOP

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-W399025
CAS No.: 1110883-26-5
Research Areas:  

Neurological Disease

ID110460001 is a full agonist of μ-opioid receptor and an agonist of δ-opioid receptor. ID110460001 exhibits high intrinsic efficacy for G protein pathway activation of μ-opioid receptor, and this property is not affected by the reduction in receptor quantity. ID110460001 acts only as a very weak partial agonist in the β-arrestin-2 pathway of both receptors, and binds to μ-opioid receptor via a specific mode. The efficacy of ID110460001 in the G protein pathway of δ-opioid receptor is sensitive to changes in receptor quantity. ID110460001 can be used in pain-related research .
loading...
    loading...